Skip to main content

Advertisement

Log in

Matteucinol, isolated from Miconia chamissois, induces apoptosis in human glioblastoma lines via the intrinsic pathway and inhibits angiogenesis and tumor growth in vivo

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Gliomas account for nearly 70% of the central nervous system tumors and present a median survival of approximately 12–17 months. Studies have shown that administration of novel natural antineoplastic agents is been highly effective for treating gliomas. This study was conducted to investigate the antitumor potential (in vitro and in vivo) of Miconia chamissois Naudin for treating glioblastomas. We investigated the cytotoxicity of the chloroform partition and its sub-fraction in glioblastoma cell lines (GAMG and U251MG) and one normal cell line of astrocytes. The fraction showed cytotoxicity and was selective for tumor cells. Characterization of this fraction revealed a single compound, Matteucinol, which was first identified in the species M. chamissois. Matteucinol promoted cell death via intrinsic apoptosis in the adult glioblastoma lines. In addition, Matteucinol significantly reduced the migration, invasion, and clonogenicity of the tumor cells. Notably, it also reduced tumor growth and angiogenesis in vivo. Moreover, this agent showed synergistic effects with temozolomide, a chemotherapeutic agent commonly used in clinical practice. Our study demonstrates that Matteucinol from M chamissois is a promising compound for the treatment of glioblastomas and may be used along with the existing chemotherapeutic agents for more effective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R (2010) Gliomas in adults. Dtsch Arztebl Int 107(45):799–807

    PubMed  PubMed Central  Google Scholar 

  2. Hour M-J, Liu W-T, Lu I-C, Kuo S-C, Gean P-W (2014) Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline. Am J Cancer Res 4(5):474–483

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Sitarek P, Skała E, Toma M, Wielanek M, Szemraj J, Skorski T, Białas AJ, Sakowicz T, Kowalczyk T, Radek M (2016) Transformed root extract of Leonurus sibiricus induces apoptosis through intrinsic and extrinsic pathways in various grades of human glioma cells. Pathol Oncol Res 23(3):679–687

    Article  Google Scholar 

  4. Zhang Y, Xie R-F, Xiao Q-G, Li R, Shen X-L, Zhu X-G (2014) Hedyotis diffusa Willd extract inhibits the growth of human glioblastoma cells by inducing mitochondrial apoptosis via AKT/ERK pathways. J Ethnopharmacol 158:404–411

    Article  Google Scholar 

  5. de Rezende AR, Romero R, Goldenberg R (2014) Sinopse de Miconia seção Miconia Dc. (Melastomataceae) no estado de Minas Gerais, Brasil Synopsis of Miconia section Miconia Dc. (Melastomataceae) in the state of Minas Gerais, Brazil. Biosci J 30(1)

  6. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, ShiratakI Y, Sakagami H (2005) Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25(3B):2055–2063

    CAS  PubMed  Google Scholar 

  7. Kuster R, Caxito M, Sabino K, da Costa H, Tose L, Romão W, Vaz B, Silva A (2015) Identification of maloyl glucans from Euphorbia tirucalli by ESI(−)-FT-ICR MS analyses. Phytochem Lett 12:209–214

    Article  CAS  Google Scholar 

  8. Kill JB, Oliveira IF, Tose LV, Costa HB, Kuster RM, Machado LF, Correia RM, Rodrigues RR, Vasconcellos GA, Vaz BG (2016) Chemical characterization of synthetic cannabinoids by electrospray ionization FT-ICR mass spectrometry. Forensic Sci Int 266:474–487

    Article  CAS  Google Scholar 

  9. Amitani M, Cheng K-C, Asakawa A, Amitani H, Kairupan TS, Sameshima N, Shimizu T, Hashiguchi T, Inui A (2015) Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors. PeerJ. 3:e1105

    Article  Google Scholar 

  10. Silva-Oliveira RJ, Lopes GF, Camargos LF, Ribeiro AM, Santos FV, Severino RP, VGP S, Terezan AP, Thomé RG, Santos HB (2016) Tapirira guianensis Aubl. Extracts inhibit proliferation and migration of oral cancer cells lines. Int J Mol Sci 17(11):1839

    Article  Google Scholar 

  11. Chuang YF, Huang SW, Hsu YF, Yu MC, Ou G, Huang WJ, Hsu MJ (2017) WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via SHP-1-STAT3-survivin cascade. Br J Pharmacol 174(17):2941–2961

    Article  CAS  Google Scholar 

  12. Li Y, Guo G, Song J, Cai Z, Yang J, Chen Z, Wang Y, Huang Y, Gao Q (2017) B7-H3 promotes the migration and invasion of human bladder cancer cells via the PI3K/Akt/STAT3 signaling pathway. J Cancer 8(5):816–824

    Article  CAS  Google Scholar 

  13. Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul 22:27–55

    Article  CAS  Google Scholar 

  14. Chou T-C, Talaly P (1977) A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem 252(18):6438–6442

    CAS  PubMed  Google Scholar 

  15. Hagedorn M, Javerzat S, Gilges D, Meyre A, de Lafarge B, Eichmann A, Bikfalvi A (2005) Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci U S A 102(5):1643–1648

    Article  CAS  Google Scholar 

  16. Zhao J, Ding HX, Zhao DG, Wang CM, Gao K (2012) Isolation, modification and cytotoxic evaluation of flavonoids from Rhododendron hainanense. J Pharm Pharmacol 64(12):1785–1792

    Article  CAS  Google Scholar 

  17. Van T et al (2018) Isolation and purification of potent growth inhibitors from Piper methysticum root. Molecules 23(8):1907

    Article  Google Scholar 

  18. Perrin SL, Samuel MS, Koszyca B, Brown MP, Ebert LM, Oksdath M, Gomez GA (2019) Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments. Biochemical Society Transactions. BST20180444

  19. Park C-K, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW (2013) The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma. J Neuro-Oncol 112(2):277–283

    Article  CAS  Google Scholar 

  20. Zhang J, Stevens FG, Malcolm, Bradshaw D, Tracey (2012) Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5(1):102–114

    Article  CAS  Google Scholar 

  21. Johannessen TCA, Bjerkvig R (2012) Molecular mechanisms of temozolomide resistance in glioblastoma multiforme. Expert Rev Anticancer Ther 12(5):635–642

    Article  CAS  Google Scholar 

  22. Zhu Y, Fang J, Wang H, Fei M, Tang T, Liu K, Zhou Y (2018) Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca2+-dependent pathway. Drug Des Dev Ther 12:3247

    Article  CAS  Google Scholar 

  23. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR (2003) Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5(7):647–654

    Article  CAS  Google Scholar 

  24. Zhang D et al (2013) Two new C-methyl flavanones from the rhizomes and frond bases of Matteuccia struthiopteris. J Asian Nat Prod Res 15(11):1163–1167

    Article  CAS  Google Scholar 

  25. Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischaemia–reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61(3):448–460

    Article  CAS  Google Scholar 

  26. Steelman LS, Chappell WH, Abrams SL, Kempf CR, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC (2011) Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) 3(3):192

    Article  CAS  Google Scholar 

  27. Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A (2002, 2002) DNA damage-induced G2–M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4(12):993–997

  28. Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA (2012) Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 327(1):123–133

    Article  CAS  Google Scholar 

  29. Chang Y-L et al (2017) The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines. Int J Biochem Cell Biol 92:155–163

    Article  CAS  Google Scholar 

  30. Yan X et al (2014) Ginsenoside rb1 protects neonatal rat cardiomyocytes from hypoxia/ischemia induced apoptosis and inhibits activation of the mitochondrial apoptotic pathway. Evid Based Complement Alternat Med

  31. Gao G, Jiang YW, Yang J, Wu FG (2017) Mitochondria-targetable carbon quantum dots for differentiating cancerous cells from normal cells. Nanoscale. 9(46):18368–18378

    Article  CAS  Google Scholar 

  32. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell. 144(5):646–674

    Article  CAS  Google Scholar 

  33. Huse JT, Holland E, Deangelis LM (2013) Glioblastoma: molecular analysis and clinical implications. Annu Rev Med 64:59–70

    Article  CAS  Google Scholar 

  34. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315–2319

    Article  CAS  Google Scholar 

  35. Teicher BA (2009) In vivo/ex vivo and in situ assays used in cancer research: a brief review. Toxicol Pathol 37(1):114–122

    Article  CAS  Google Scholar 

  36. Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang SF, Chiang WL, Chu SC (2007) The tumor-growth inhibitory activity of flavanone and 2′-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. J Biomed Sci 14(1):107–119

    Article  CAS  Google Scholar 

  37. Kargiotis O, Rao J, Kyritsis A (2006) Mechanisms of angiogenesis in gliomas. J Neuro-Oncol 78(3):281–293

    Article  CAS  Google Scholar 

  38. Onishi M, Ichikawa T, Kurozumi K, Date I (2011) Angiogenesis and invasion in glioma. Brain Tumor Pathol 28:13–24

    Article  CAS  Google Scholar 

  39. Grogan PT, Sarkaria JN, Timmermann BN, Cohen MS (2014) Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Investig New Drugs 32(4):604–617

    Article  CAS  Google Scholar 

  40. Lee HS, Cho HJ, Yu R, Lee KW, Chun HS, Park JHY (2014) Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells. Int J Mol Sci 15(2):2722–2737

    Article  Google Scholar 

Download references

Funding

The work was supported by Minas Gerais State Research Foundation (FAPEMIG), National Council for Scientific and Technological Development (CNPq),and supported partially by grantsfrom the FINEP (MCTI/ FINEP/MS/SCTIE/DECIT-01/2013 - FPXII-BIOPLAT). This work was conducted during a scholarship supported by the International Cooperation Program CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education within the Ministry of Education of Brazil) at the Federal University of São João del Rei.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Rui Manuel Reis or Rosy Iara Maciel de Azambuja Ribeiro.

Ethics declarations

Conflict of interest

Author Silva, A.G. declares that she has no conflict of interest. Author Saito, V.A.O.S. declares that she has no conflict of interest. Author Oliveira R.J.S. declares that he has no conflict of interest. Author Rezende, A.R. declares that he has no conflict of interest. Author Chagas R.C.R. declares that he has no conflict of interest. Author Pimenta, L.P.S. declares that she has no conflict of interest. Author Romão, W. declares that he has no conflict of interest. Author Santos, H.B. declares that he has no conflict of interest. Author Thomé R.G. declares that he has no conflict of interest. Author Reis, R. declares that he has no conflict of interest. Author Ribeiro, R.I.M.A. declares that she has no conflict of interest.

Ethical approval

This article has a study with animals, ethical approval was obtained by the Ethics Committee of the Foundation Pio XII IRCAD Brazil under protocol number 027/2016. All applicable international, national, institutional guidelines for the care and use of animals were followed.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Table S1

(PDF 249 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, A.G., Silva, V.A.O., Oliveira, R.J.S. et al. Matteucinol, isolated from Miconia chamissois, induces apoptosis in human glioblastoma lines via the intrinsic pathway and inhibits angiogenesis and tumor growth in vivo. Invest New Drugs 38, 1044–1055 (2020). https://doi.org/10.1007/s10637-019-00878-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-019-00878-1

Keywords

Navigation